Key terms
About JAZZ
Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest JAZZ news
Apr 08
10:00pm ET
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Bluebird Bio (BLUE), Sarepta Therapeutics (SRPT) and Jazz Pharmaceuticals (JAZZ)
Apr 02
7:34am ET
Jazz completes rolling submission of BLA for zanidatamab antibody
Mar 24
9:50pm ET
Analysts Are Bullish on Top Healthcare Stocks: Immatics (IMTX), Vor Biopharma (VOR)
Mar 21
2:20am ET
Optimistic Outlook on Jazz Pharmaceuticals’ Zanidatamab Across Multiple Cancer Types: A Buy Rating Analysis
Mar 20
7:21am ET
Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (PRAX), Clene (CLNN) and Jazz Pharmaceuticals (JAZZ)
Mar 20
7:17am ET
Truist Financial Remains a Buy on Jazz Pharmaceuticals (JAZZ)
Mar 20
6:58am ET
Jazz Pharmaceuticals price target raised to $188 from $171 at Piper Sandler
Mar 20
6:45am ET
Buy Rating Affirmed for Jazz Pharmaceuticals on Strong Zanidatamab Revenue Prospects and Clinical Milestones
Mar 20
6:10am ET
Analysts Offer Insights on Healthcare Companies: BridgeBio Pharma (BBIO) and Jazz Pharmaceuticals (JAZZ)
Mar 20
5:10am ET
Analysts Offer Insights on Healthcare Companies: Jazz Pharmaceuticals (JAZZ), Shockwave Medical (SWAV) and Healthequity (HQY)
Mar 15
9:22am ET
Jazz Pharmaceuticals price target raised to $230 from $225 at Stifel
Mar 14
6:20am ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: Neurocrine (NBIX), Jazz Pharmaceuticals (JAZZ) and scPharmaceuticals (SCPH)
Mar 12
6:25am ET
Zymeworks price target raised to $14 from $12 at Wells Fargo
Mar 07
7:15am ET
TD Cowen Remains a Buy on Jazz Pharmaceuticals (JAZZ)
Mar 05
8:30am ET
Avadel Pharmaceuticals price target raised to $22 from $20 at Needham
Mar 05
8:28am ET
Avadel Pharmaceuticals price target raised to $22 from $20 at Craig-Hallum
Mar 05
7:41am ET
Avadel Pharmaceuticals price target raised to $29 from $27 at Oppenheimer
Mar 04
3:41pm ET
Avadel Pharmaceuticals ‘pleased’ with ruling in patent litigation with Jazz Pharmaceuticals
Mar 04
3:12pm ET
Avadel volatility attributed to ruling in patent fight with Jazz Pharmaceuticals
Mar 04
12:20am ET
5 Best Biotech Stocks to Buy Now, According to Analysts – March 2024
Mar 01
5:39am ET
Jazz Pharmaceuticals price target lowered to $230 from $235 at Barclays
Mar 01
5:04am ET
Analysts Offer Insights on Healthcare Companies: Penumbra (PEN), Jazz Pharmaceuticals (JAZZ) and Argenx Se (ARGX)
Mar 01
3:00am ET
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Jazz Pharmaceuticals (JAZZ), Puma Biotechnology (PBYI) and MoonLake Immunotherapeutics (MLTX)
Mar 01
1:12am ET
Jazz Pharmaceuticals: A Buy Rating Backed by Solid Growth Prospects and Strong Pipeline
Mar 01
1:10am ET
Analysts Are Bullish on Top Healthcare Stocks: Jazz Pharmaceuticals (JAZZ), Oculis Holding (OCS)
Feb 29
8:53am ET
Jazz Pharmaceuticals price target lowered to $220 from $225 at Needham
Feb 29
8:20am ET
Analysts Offer Insights on Healthcare Companies: Merit Medical Systems (MMSI), Jazz Pharmaceuticals (JAZZ) and Cooper Co (COO)
Feb 29
7:50am ET
Analysts Offer Insights on Healthcare Companies: Merit Medical Systems (MMSI), Jazz Pharmaceuticals (JAZZ) and Natera (NTRA)
Feb 29
7:48am ET
Jazz Pharmaceuticals price target lowered to $173 from $184 at BofA
Feb 29
7:31am ET
Analysts Are Bullish on These Healthcare Stocks: Addus Homecare (ADUS), Jazz Pharmaceuticals (JAZZ)
Feb 29
7:20am ET
Jazz Pharmaceuticals (JAZZ) Receives a Rating Update from a Top Analyst
JAZZ Financials
Key terms
Ad Feedback
JAZZ Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
JAZZ Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range